In routine microbiology, the decisive observation is often the last step of a chain that began with sampling and preparation. BROMOCRESOL Purple Azide Broth Culture Media is one link in that chain. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 610321 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.
Analytical scope and method role
BROMOCRESOL PURPLE AZIDE BROTH is a medium in powder used in the bacteriological analysis of water as confirmation of presence of enterococci, after preliminary test with AZIDE DEXTROSE BROTH (ref. 610003).
Method principle
Tryptone and yeast extract provide nitrogen and other nutrients necessary to support the bacterial growth. Sodium chloride keeps the osmotic balance of the medium. Sodium azide inhibits the bacterial flora grown during the preliminary test, except for enterococci. Glucose fermentation causes medium acidification with consequent medium color change from purple to yellow. The addition of glycerol increases glucose fermentation by enterococci.
Formula and functional interpretation
(g/l) Triptone 10.0 Yeast extract 10.0 Glucose 5.0 Sodium chloride 5.0 Potassium Phosphate monobasic 2.7 Potassium Phosphate dibasic 2.7 Sodium azide 0.5 Bromocresol purple 0.032 pH finale 7.0 ± 0.2
Review the nutritive, selective, differential, buffering, reducing, and indicator components against the expected target and background flora. Preparation errors can change recovery, inhibition, colour development, or endpoint visibility even when incubation is correct.
Preparation and execution: controlled method points
Preparation: Suspend 36.0 g of powder into 1 liter of distilled or deionized water. Add 5 mL of glycerol. Mix carefully. Dispense into final containers. Sterilize at 115 °C for 15 minutes.
Procedure: For the performance of confirmation trial, transfer three loops of culture broth from each positive tube of AZIDE DEXTROSE BROTH into tubes of BROMOCRESOL PURPLE AZIDE BROTH. Incubate at 36+/-1 °C up to 48 hours.
Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.
Quality control: what the control result protects
of confirmation trial, transfer three loops of culture broth from each positive tube of AZIDE DEXTROSE BROTH into tubes of BROMOCRESOL PURPLE AZIDE BROTH. Incubate at 36+/-1 °C up to 48 hours.
Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.
Interpretation and confirmation pathway
The evidence of turbidity and the color change from purple to yellow of the tube of BROMOCRESOL PURPLE AZIDE BROTH confirm enteroccocci presence.
Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.
Storage, stability, and pre-use inspection
CONDITIONS 10-30 °C away from light, until the expiry date indicated on the label or until signs of deterioration or contamination are evident. WARNING AND PRECAUTION BROMOCRESOL PURPLE AZIDE BROTH contains substances classified as harmful by current legislation; for its use it is recommended to consult the safety data sheet. The product must be used only by properly trained operators.
Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.
Limitations and boundaries of use
Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.
Troubleshooting from evidence, not guesswork
- Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
- Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
- Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
- Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.
External method context
The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.
External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.
EUCAST disk diffusion and quality control
EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.
FDA Bacteriological Analytical Manual
FDA BAM methods organize food microbiology around validated sampling, preparation, enrichment, isolation, and confirmation steps, with method applicability tied to the matrix and target organism. Sampling uncertainty, homogenization efficiency, inhibitory ingredients, dilution design, and countable range can dominate the result before the culture medium is ever inoculated; those variables belong in method verification and uncertainty review. Review the authoritative source.
WHO Laboratory Quality Management System handbook
WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.
Technical references
- Manufacturer product documentation for catalogue 610321.
- EUCAST disk diffusion and quality control (access checked 2026-07-20).
- FDA Bacteriological Analytical Manual (access checked 2026-07-20).
- WHO Laboratory Quality Management System handbook (access checked 2026-07-20).
Bench-use checklist
- Verify product identity, catalogue number, lot, expiry, and storage history.
- Document preparation and incubation exactly as controlled in the SOP.
- Define controls and acceptance criteria before testing.
- Record raw observations, control response, reading time, and confirmation decision.
- Escalate failed controls, atypical reactions, and departures through the quality system.